Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 13 Nov 2023 for Intercept Pharmaceuticals, INC., €636k.
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Paolo Fundaro: trading record in brief
Paolo Fundaro is a declared insider of Intercept Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). In total, 18 filings cover trades dated from 19 July 2016 to 8 November 2023.
No open-market purchase appears, only 6 sales worth €106.8M. Outside the open market, there are 8 share grants and 2 option exercises.
Most recently, on 13 November 2023, the filings show a transaction worth €144k in Intercept Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paolo Fundaro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
35,794 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117113:0
8,111 shares0Common StockSEC:0001104659-23-064843:0
7,737 shares0Common StockSEC:0001104659-22-065927:0
7,029 shares0Common StockSEC:0001104659-21-075218:0
4 of 4 declarations
